1-deoxynojirimycin has been researched along with Impaired Glucose Tolerance in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eitsuka, T; Ikeda, R; Ito, J; Kimura, T; Nakagawa, K; Parida, IS; Takasu, S; Yamagishi, K | 1 |
| Hu, B; Hu, H; Jiang, N; Liu, H; Ma, J; Yang, H; Zhang, Z; Zheng, J; Zhu, L; Zou, X | 1 |
| Aerts, JM; Aten, J; Dubbelhuis, PF; Grefhorst, A; Kuipers, F; O'Rahilly, S; Ottenhoff, R; Overkleeft, HS; Powlson, AS; Serlie, MJ; Sethi, JK; van Eijk, M; Wennekes, T | 1 |
| Chiasson, JL; Rabasa-Lhoret, R | 1 |
1 review(s) available for 1-deoxynojirimycin and Impaired Glucose Tolerance
| Article | Year |
|---|---|
Potential of alpha-glucosidase inhibitors in elderly patients with diabetes mellitus and impaired glucose tolerance.
Topics: 1-Deoxynojirimycin; Acarbose; Aged; Body Weight; Cognition; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glucosamine; Glucose Intolerance; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses; Trisaccharides | 1998 |
3 other study(ies) available for 1-deoxynojirimycin and Impaired Glucose Tolerance
| Article | Year |
|---|---|
Supplementation of Bacillus amyloliquefaciens AS385 culture broth powder containing 1-deoxynojirimycin in a high-fat diet altered the gene expressions related to lipid metabolism and insulin signaling in mice epididymal white adipose tissue.
Topics: 1-Deoxynojirimycin; Adipokines; Adipose Tissue, White; Animals; Bacillus amyloliquefaciens; Blood Glucose; Diet, High-Fat; Dietary Supplements; Epididymis; Gene Expression Regulation; Glucose Intolerance; Insulin; Lipid Metabolism; Lipids; Male; Mice; Mice, Inbred C57BL; Signal Transduction | 2020 |
1-Deoxynojirimycin improves high fat diet-induced nonalcoholic steatohepatitis by restoring gut dysbiosis.
Topics: 1-Deoxynojirimycin; Animals; Diet, High-Fat; Dysbiosis; Gastrointestinal Microbiome; Glucose Intolerance; Hepatitis; Insulin; Lipids; Male; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease | 2019 |
Pharmacological inhibition of glucosylceramide synthase enhances insulin sensitivity.
Topics: 1-Deoxynojirimycin; 3T3 Cells; Adamantane; Adipocytes; Animals; Ceramides; Enzyme Inhibitors; Glucose Intolerance; Glucosylceramides; Glucosyltransferases; Glycosphingolipids; Humans; Insulin; Liver; Mice; Mice, Inbred C57BL; Mice, Obese; Pancreas; Signal Transduction | 2007 |